Default company panoramic image

JB Therapeutics Inc

JBT is developing ajulemic acid (AJA) a nonpsychotropic synthetic THC derivative for the treatment of scleroderma & other fibrotic diseases

  • Stage Concept Only
  • Industry Biotechnology
  • Location Newton, MA, USA
  • Currency USD
  • Employees 5
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.